Study of fetal Health Outcomes: Working with a Missouri E-telehealth Platform (The Show-Me Study)

The purpose of this study is to establish ease of use, satisfaction, and potential cost-savings associated with the use of an in-home fetal monitoring system. The NUVO fetal monitoring system is an FDA-approved device to monitor fetal health through a non-stress test which is normally performed in the hospital or doctor's office. You will be evaluated by your doctor for inclusion into the study and if you indeed are eligible, you will be asked if you want to participate. Because we don't know whether fetal monitoring at home or in the office is best, we will "randomize" you into one of the two study groups. "Randomize" means putting you into a group by chance. It is like flipping a coin or pulling a number from a hat. You will have an equal chance of being placed in either group. You and the study doctor cannot choose which group you go into. If you agree to be part of the study, you will be asked to draw an envelope which will tell you whether you will continue care in the office setting or if you will be selected to have home monitoring with Nuvo.